Retrobulbar and peripheral capillary blood flow in hypercholesterolemic subjects

American Journal of Ophthalmology

Volumn 128, Issue 3, 1999, Pages 310-316

  Senn, Brigitte ^a   Orgul, Selim ^a   Keller, Ulrich ^b   Dickermann, Denise ^b   Dubler, Barbara ^a   Vavrecka, Jana ^a   Gasser, Paul ^a   Kaiser, Hedwig J ^a   Flammer, Josef ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CAPILLARY FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE BLOOD FLOW; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FINGER NAIL; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION; VISUAL FIELD;

ANTILIPEMIC AGENTS; BLOOD FLOW VELOCITY; CAPILLARIES; CILIARY ARTERIES; FEMALE; FINGERS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; NAILS; OPHTHALMIC ARTERY; ORBIT; RETINAL ARTERY; SIMVASTATIN; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0032829182     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00148-8     Document Type: Article

References (37)

1. Hayreh S.S., Podhajsky P. Ocular neovascularization with retinal vascular occlusion, II occurrence in central and branch retinal artery occlusion . Arch Ophthalmol. 100:1982;1585-1596.
2. Hayreh S.S., Joos K.M., Podhajsky P.A., Long C.R. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 118:1994;766-780.
3. The Lipid Research Clinics Coronary Primary Prevention Trial results, I reduction in incidence of coronary heart disease . JAMA. 251:1984;351-364.
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 344:1994;1383-1389.
5. Brown B.G., Zhao X.-Q., Sacco D.E., Albers J.J. Lipid lowering and plaque regression new insights into prevention of plaque disruption and clinical events in coronary disease . Circulation. 87:1993;1781-1791.
6. Sacks F.M., Gibson C.M., Rosner B., Pasternak R.C., Stone P.H. The influence of pretreatment low-density lipoprotein cholesterol concentrations on the effect of hypercholesterolemic therapy on coronary atherosclerosis in angiographic trials. Am J Cardiol. 76:(suppl):1995;78C-85C.
7. Levine G.N., Keaney J.F., Vita J.A. Cholesterol reduction in cardiovascular disease clinical benefits and possible mechanisms . N Engl J Med. 332:1995;512-521.
8. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;310-318.
9. Loscalzo J. Regression of coronary atherosclerosis. N Engl J Med. 323:1990;1337-1339.
10. Freiman P.C., Mitchell G.G., Heistad D.D., Armstrong M.L., Harison D.G. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res. 58:1986;783-789.
11. Harrison D.G., Freiman P.C., Armstrong M.L., Marcus M.L., Heistad D.D. Alterations of vascular reactivity in atherosclerosis. Circ Res. 61:(suppl 2):1987;74-80.
12. Chappell S.P., Lewis M.J., Henderson A.H. Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations. Cardiovasc Res. 21:1987;34-38.
13. Harrison D.G., Armstrong M.L., Freiman P.C., Heistad D.D. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest. 80:1987;1808-1811.
14. Faraci F.M., Armstrong M.L., Heistad D.D. Dietary treatment of atherosclerosis abolishes hyperresponsiveness of retinal blood vessels to serotonin in monkeys. Stroke. 22:1991;1405-1408.
15. Sobey C.Y., Faraci F.M., Piegors D.J., Heistad D.D. Effect of short-term regression of atherosclerosis on reactivity of carotid and retinal arteries. Stroke. 27:1996;927-933.
16. Hayreh S.S., Piegors D.J., Heistad D.D. Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys implications for ischemic disorders of the retina and the optic nerve head . Arch Ophthalmol. 115:1997;220-228.
17. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
18. Treasure C.B., Klein L., Weintraub W.S., et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
19. Stroes E.S.G., Koomans H.A., de Bruin T.W.A., Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 346:1995;467-471.
20. Gasser P, Orgul S, Dubler B, Bucheli B, Flammer J. Relationship between blood-flow velocities in the ophthalmic artery and in nailfold capillaries. Br J Ophthalmol. Forthcoming.
21. Rifai N., Warnick G.R., McNamara J.R., Belcher J.D., Grinstead G.F., Frantz I.D. Jr. Measurement of low-density-lipoprotein cholesterol in serum a status report . Clin Chem. 38:1992;150-160.
22. Flammer J. The concept of visual-field indices. Graefes Arch Clin Exp Ophthalmol. 224:1987;389-392.
23. Kaiser H.J., Schotzau A., Flammer J. The frequency distribution of blood-flow velocities in the extraocular vessels. Graefes Arch Clin Exp Ophthalmol. 234:1996;537-541.
24. Kaiser H.J., Schotzau A., Flammer J. Blood-flow velocities in the extraocular vessels in normal volunteers. Am J Ophthalmol. 122:1996;364-370.
25. Gasser P., Flammer J. Blood-cell velocity in the nailfold capillaries of patients with normal-tension and high-tension glaucoma. Am J Ophthalmol. 111:1991;585-588.
26. Boss C., Schneuwly P., Mahler F. Evaluation and clinical application of the flying spot method in nailfold capillary TV-microscopy. Int J Microcirc Clin Exp. 6:1987;15-23.
27. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low-density lipoproteins a potential role in recruitment and retention of monocyte/macrophages during atherogenesis . Proc Natl Acad Sci U S A. 84:1987;2995-2998.
28. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160-162.
29. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 86:1990;75-79.
30. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low-density lipoproteins inhibit relaxations of porcine coronary arteries role of scavenger receptor and endothelium-derived nitric oxide . Circulation. 83:1991;2012-2021.
31. Cathcart M.K., Morel D.W., Chisolm G.M. Monocytes and neutrophils oxidize low-density lipoproteins making it cytotoxic. J Leukoc Biol. 38:1985;341-350.
32. Henricksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of low-density lipoprotein previously incubated with cultured endothelial cells recognition by receptor for acetylated low-density lipoproteins . Proc Natl Acad Sci U S A. 78:1981;6499-6503.
33. Henrickson T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of biologically modified low-density lipoprotein. Arteriosclerosis. 3:1983;149-159.
34. de Divitiis M., Rubba P., Di Somma S., et al. Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia. Am J Cardiol. 78:1996;763-768.
35. Hayreh S.S. Evaluation of optic nerve head circulation review of the methods used . J Glaucoma. 6:1997;319-330.
36. Senn B.C., Kaiser H.J., Schotzau A., Flammer J. Reproducibility of color Doppler imaging in orbital vessels. Ger J Ophthalmol. 5:1997;386-391.
37. Flammer J., Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog Ret Eye Res. 17:1998;267-289.